Reliability of platelet-derived endothelial cell growth factor as a prognostic factor for oral and oropharyngeal carcinomas
- PMID: 16365220
- DOI: 10.1001/archotol.131.12.1071
Reliability of platelet-derived endothelial cell growth factor as a prognostic factor for oral and oropharyngeal carcinomas
Abstract
Objective: To identify a strong prognostic biological marker for patients with oral and oropharyngeal squamous cell carcinomas.
Design: We evaluated the protein expressions of 26 tumor-associated factors, including cytokines and cytokine receptors (granulocyte colony-stimulating factor [G-CSF], interleukin 10 [IL-10], G-CSF receptor [G-CSFR], and IL-12 receptor); angiogenic factors (platelet-derived endothelial cell growth factor [PD-ECGF] and vessel count); cell cycle-related proteins (p27, cyclin D1, and cyclin E); apoptosis-related factors (wild-type p53, Bax, Bcl-2, apoptotic index, Fas, and Fas ligand); oncogene proteins (c-fos and c-Myc); cell-surface proteins (P-glycoprotein, multidrug resistance-associated protein, nm23, and CD40); intracellular proteins (aryl hydrocarbon receptor nuclear translocator, aryl hydrocarbon receptor, and heat shock protein 27); and DNA mismatch-repair genes (protein encoded by human mutL homologue 1 and the human mutS homologue of the chromosome 2p gene) by means of immunohistochemical analysis.
Setting: Department of Otorhinolaryngology-Head and Neck Surgery, University of Fukui, Fukui, Japan.
Patients: Fifty-eight patients who underwent surgical resections of oral and oropharyngeal squamous cell carcinomas.
Results: A low-level PD-ECGF expression, a hypovascular count, or a low-level G-CSFR expression was associated with a favorable clinical outcome using the Kaplan-Meier method. Univariate analysis showed that PD-ECGF expression (odds, 4.19; P = .02), G-CSFR expression (odds, 4.10; P = .01), and vessel count (odds, 2.80; P = .04) had significant hazard rates. When multivariate analysis was performed on 6 factors, including sex, tumor size, lymph node metastasis, PD-ECGF expression, G-CSFR expression, and vessel count, patients with a positive expression of PD-ECGF had the highest relative risk value for death due to the disease (odds, 4.94; P = .01). Also, G-CSFR was an independent prognostic indicator in the model (odds, 3.29; P = .04). No correlations between other factors and prognoses were detected.
Conclusion: Expression of PD-ECGF was the most effective marker for making prognoses for oral and oropharyngeal squamous cell carcinomas, and G-CSFR expression was the second most effective among 26 tumor-associated factors.
Similar articles
-
Expression of platelet-derived endothelial cell growth factor in oral and oropharyngeal carcinoma.Clin Cancer Res. 1998 Jul;4(7):1583-90. Clin Cancer Res. 1998. PMID: 9676830
-
Expression of granulocyte colony-stimulating factor receptor and platelet-derived endothelial cell growth factor in oral and oropharyngeal precancerous lesions.Anticancer Res. 2001 Jul-Aug;21(4B):2901-6. Anticancer Res. 2001. PMID: 11712784
-
Influence of platelet-derived endothelial cell growth factor/thymidine phosphorylase on the cell cycle in head and neck squamous cell carcinoma in vitro.Oncol Rep. 2003 Jul-Aug;10(4):967-71. Oncol Rep. 2003. PMID: 12792754
-
Platelet-derived endothelial cell growth factor.J Cell Biochem. 1991 Nov;47(3):208-10. doi: 10.1002/jcb.240470304. J Cell Biochem. 1991. PMID: 1724243 Review.
-
[Prognostic factors for head and neck cancer].Gan To Kagaku Ryoho. 2001 Apr;28(4):440-7. Gan To Kagaku Ryoho. 2001. PMID: 11329776 Review. Japanese.
Cited by
-
A possible role of thymidine phosphorylase expression and 5-fluorouracil increased sensitivity in oropharyngeal cancer patients.J Cell Mol Med. 2007 Mar-Apr;11(2):362-8. doi: 10.1111/j.1582-4934.2007.00007.x. Epub 2007 Mar 22. J Cell Mol Med. 2007. PMID: 17378915 Free PMC article.
-
The prognostic role of NK cells and their ligands in squamous cell carcinoma of the head and neck: a systematic review and meta-analysis.Oncoimmunology. 2020 Apr 23;9(1):1747345. doi: 10.1080/2162402X.2020.1747345. eCollection 2020. Oncoimmunology. 2020. PMID: 32363116 Free PMC article.
-
Molecular profiling of cervical cancer progression.Br J Cancer. 2007 Jan 29;96(2):321-8. doi: 10.1038/sj.bjc.6603543. Br J Cancer. 2007. PMID: 17242701 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous